Stereotaxis (STXS) shares are higher after the company won a patent covering the transmission of data for its Odyssey Information Management Solution.
Shares of Stereotaxis (STXS) are up today after announcing that it has received 510(k) clearance by the FDA for its Vdrive(R) with V-CAS(TM) Catheter Advancement System in the U.S.
Stocks with insider trader activity include CODE, COV and STXS
These stocks are poised to break out and trade higher from current levels.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.